Mutamycin Side Effects
Generic name: mitomycin
Medically reviewed by Drugs.com. Last updated on Mar 27, 2025.
Note: This document provides detailed information about Mutamycin Side Effects associated with mitomycin. Some dosage forms listed on this page may not apply specifically to the brand name Mutamycin.
Applies to mitomycin: intravenous powder for solution.
Important warnings
This medicine can cause some serious health issues
Intravenous route (powder for solution)
Mitomycin should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents.
Appropriate management of therapy and complications is possible only when adequate diagnostic and treatment facilities are readily available.
Bone marrow suppression, notably thrombocytopenia and leukopenia, which may contribute to overwhelming infections in an already compromised patient, is the most common and severe of the toxic effects of mitomycin. Hemolytic Uremic Syndrome (HUS), a serious complication of chemotherapy consisting primarily of microangiopathic hemolytic anemia, thrombocytopenia, and irreversible renal failure, has been reported in patients receiving systemic mitomycin.
The syndrome may occur at any time during systemic therapy with mitomycin as a single agent or in combination with other cytotoxic drugs; however, most cases occur at doses greater than or equal to 60 mg of mitomycin.
Blood product transfusion may exacerbate the symptoms associated with this syndrome.
The incidence of the syndrome has not been defined.
Precautions
It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly and to check for unwanted effects.
While you are being treated with mitomycin (the active ingredient contained in Mutamycin) and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval. Mitomycin may lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent. In addition, other persons living in your household should not take oral polio vaccine since there is a chance they could pass the polio virus on to you. Also, avoid persons who have taken oral polio vaccine. Do not get close to them, and do not stay in the same room with them for very long. If you cannot take these precautions, you should consider wearing a protective face mask that covers the nose and mouth.
Mitomycin can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:
- If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.
- Check with your doctor immediately if you notice any unusual bleeding or bruising; black, tarry stools; blood in urine or stools; or pinpoint red spots on your skin.
- Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.
- Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.
- Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.
- Avoid contact sports or other situations where bruising or injury could occur.
If mitomycin accidentally seeps out of the vein into which it is injected, it may damage the skin and cause scarring. In some patients, this may occur weeks or even months after this medicine is given. Tell the doctor or nurse right away if you notice redness, pain, or swelling at the place of injection or anywhere else on your skin.
Common side effects of Mutamycin
Some side effects of mitomycin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- loss of appetite
- nausea and vomiting
Less common side effects
- numbness or tingling in fingers and toes
- purple-colored bands on nails
- skin rash
- unusual tiredness or weakness
Mitomycin sometimes causes a temporary loss of hair. After treatment has ended, normal hair growth should return.
After you stop using this medicine, it may still produce some side effects that need attention. During this period of time, Check with your doctor immediately if you notice the following side effects:
- blood in urine
Also, check with your doctor if you notice any of the following:
- black, tarry stools
- blood in stools
- cough or hoarseness
- decreased urination
- fever or chills
- lower back or side pain
- painful or difficult urination
- pinpoint red spots on skin
- red or painful skin
- shortness of breath
- swelling of feet or lower legs
- unusual bleeding or bruising
Serious side effects of Mutamycin
Along with its needed effects, mitomycin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Also, because of the way cancer medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or years after the medicine is used. These delayed effects may include certain types of cancer. Discuss these possible effects with your doctor.
Check with your doctor immediately if any of the following side effects occur while taking mitomycin:
Less common side effects
- black, tarry stools
- blood in urine or stools
- cough or hoarseness
- fever or chills
- lower back or side pain
- painful or difficult urination
- pinpoint red spots on skin
- unusual bleeding or bruising
- cough
- decreased urination
- shortness of breath
- sores in mouth and on lips
- swelling of feet or lower legs
Rare side effects
- redness or pain, especially at place of injection
- bloody vomit
Check with your doctor as soon as possible if any of the following side effects occur while taking mitomycin:
For healthcare professionals
Applies to mitomycin: compounding powder, intravenous powder for injection, intravesical solution, ureteral kit.
Hematologic adverse events
- Very common (10% or more): Bone marrow toxicity (64%), thrombocytopenia, leucopenia, pancytopenia, neutropenia, granulocytopenia, erythropenia, microangiopathic hemolytic anemia, myelodysplastic syndrome, thrombotic thrombocytopenic purpura[Ref]
Other
- Very common (10% or more): Fever (14%)
- Frequency not reported: Fatigue, edema, pain[Ref]
Dermatologic
- Common (1% to 10%): Allergic skin rash, contact dermatitis, palmar-plantar erythema, pruritus, exanthema, integument and mucous membrane toxicity
- Uncommon (0.1% to 1%): Alopecia[Ref]
Respiratory
- Common (1% to 10%): Interstitial pneumonia, dyspnea, cough, shortness of breath
- Rare (less than 0.1%): Pulmonary hypertension, pulmonary veno-occlusive disease (PVOD)[Ref]
Renal
- Common (1% to 10%): Renal dysfunction, increase in serum creatinine, glomerulopathy, nephrotoxicity
- Rare (less than 0.1%): Hemolytic uremic syndrome (HUS) (commonly fatal), microangiopathic-hemolytic anemia (MAHA syndrome)[Ref]
Cardiovascular
- Rare (less than 0.1%): Heart failure (after previous therapy with anthracyclines)[Ref]
Gastrointestinal
- Very common (10% or more): Anorexia (14%), nausea (14%), vomiting (14%)
- Uncommon (0.1% to 1%): Mucositis, stomatitis, diarrhea[Ref]
Genitourinary
- Common (1% to 10%): Cystitis (possibly hemorrhagic), dysuria, nocturia, pollakiuria, hematuria, local irritation of the bladder wall
- Very rare (less than 0.01%): Necrotizing cystitis, allergic (eosinophilic) cystitis, stenosis of the efferent urinary tract, reduced bladder capacity, bladder wall calcification, bladder wall fibrosis, bladder perforation
- Frequency not reported: Increased frequency of micturition, rash and pruritus on hands and genital area
- Postmarketing reports: Bladder fibrosis/contraction rarely requiring cystectomy[Ref]
Hypersensitivity
- Very rare (less than 0.01%): Severe allergic reaction[Ref]
Immunologic
- Rare (0.01% to 0.1%): Life-threatening infection (e.g., bacterial, viral, fungal), sepsis, hemolytic anemia
- Frequency not reported: Septic shock[Ref]
Local
- Common (1% to 10%): Following extravasation: Cellulitis, tissue necrosis[Ref]
Ocular
- Frequency not reported: Blurred vision[Ref]
Psychiatric
- Frequency not reported: Confusion[Ref]
Hepatic
- Rare (less than 0.1%): Liver dysfunction, increased transaminases, jaundice, veno-occlusive disease (VOD)[Ref]
Oncologic
- Frequency not reported: Myelodysplastic syndrome, acute myeloid leukemia, acute leukemia[Ref]
Nervous system
- Frequency not reported: Headache, drowsiness, syncope[Ref]
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Lynparza
Lynparza (olaparib) is used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate ...
Everolimus
Everolimus (Afinitor, Afinitor Disperz, Zortress) belongs to a class of drugs called kinase ...
Olaparib
Olaparib (Lynparza) is a PARP inhibitor used to treat breast cancer, prostate, ovarian, and ...
Gemcitabine
Gemcitabine systemic is used for breast cancer, breast cancer, metastatic, nasopharyngeal ...
Doxorubicin
Doxorubicin systemic is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder ...
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. Cerner Multum, Inc. "Australian Product Information."
3. (2022) "Product Information. MitoMYcin (mitoMYcin)." BluePoint Laboratories
More about Mutamycin (mitomycin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (1)
- Dosage information
- During pregnancy
- Drug class: antibiotics/antineoplastics
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Mutamycin side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.